Abstract
Antimicrobial drug resistance has made the treatment of microbial infections quite challenging. A Gram-positive, anaerobic, spore-forming, and toxin-producing bacillus, Clostridioides difficile infection causes diarrhea-related deaths globally. The available drugs like vancomycin and metronidazole are becoming less effective against this infection. We have designed this study to identify genes responsible for antimicrobial resistance and have a better understanding of the mutations and their impact on the antimicrobial resistance activity. The Whole Genome Sequencing data of 11 C. difficile clinical isolates was analyzed to determine novel genes playing a significant role in antimicrobial resistance mechanisms. Comparative structure analysis of wild and mutant structures of proteins and their functions provided insight into the impact of the identified mutations on antimicrobial resistance. We identified 8 genes common in all the isolates that play a vital role in drug resistance through antibiotic efflux, ribosomal protection, and antibiotic inactivation. Variations in the functional domains of tetA(P), tetM, and ermB genes were found to be the most promising novel drug targets. Our findings suggest that these novel gene mutations would be beneficial in designing new drugs to combat C. difficile infection.
REFERENCES
Czepiel, J., Dróżdż M, Pituch, H., Kuijper, E.J., Perucki, W., Mielimonka, A., et al., Clostridium difficile infection: Review, Eur. J. Clin. Microbiol. Infect. Dis., 2019, vol. 38, no. 7, pp. 1211–1221.
Turner, N.A. and Anderson, D.J., Hospital infection control: Clostridioides difficile, Clin. Colon Rectal Surg., 2020, vol. 33, no. 02, pp. 098–108.
Lim, S.C., Riley, T.V., Knight, D.R., Lim, S.C., Riley, T.V., and Knight, D.R., One health: The global challenge of Clostridium difficile infection, Microbiol. Aust., 2020, vol. 41, no. 1, pp. 23–27.
Smits, W.K., Lyras, D., Lacy, D.B., Wilcox, M.H., and Kuijper, E.J., Clostridium difficile infection, Nat. Rev. Dis. Primers, 2016, vol. 2, p. 16020.
Haran, J.P., Ward, D.V., Bhattarai, S.K., Loew, E., Dutta, P., Higgins, A., et al., The high prevalence of Clostridioides difficile among nursing home elders associates with a dysbiotic microbiome, Gut Microbes, 2021, vol. 13, no. 1, pp. 1–15.
Lessa, F.C., Winston, L.G., and McDonald, L.C., Emerging Infections Program C. difficile Surveillance Team, Burden of Clostridium difficile infection in the United States, N. Engl. J. Med., 2015, vol. 372, no. 24, pp. 2369–2370.
Chitnis, A.S., Holzbauer, S.M., Belflower, R.M., Winston, L.G., Bamberg, W.M., Lyons, C., et al., Epidemiology of community-associated Clostridium difficile infection, 2009 Through 2011, JAMA Intern. Med., 2013, vol. 173, no. 14, pp. 1359–1367.
Cohen, B., Cohen, C.C., Løyland, B., and Larson, E.L., Transmission of health care-associated infections from roommates and prior room occupants: A systematic review, Clin. Epidemiol., 2017, vol. 9, pp. 297–310.
Khanafer, N., Vanhems, P., Barbut, F., and Luxemburger, C., Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort, Anaerobe, 2017, vol. 44, pp. 117–123.
Di Bella, S., Ascenzi, P., Siarakas, S., Petrosillo, N., and di Masi A., Clostridium difficile toxins A and B: Insights into pathogenic properties and extraintestinal effects, Toxins, 2016, vol. 8, no. 5, p. 134.
Baines, S.D. and Wilcox, M.H., Antimicrobial resistance and reduced susceptibility in Clostridium difficile: Potential consequences for induction, treatment, and recurrence of C. difficile infection, Antibiotics, 2015, vol. 4, no. 3, pp. 267–298.
Sun, X. and Hirota, S.A., The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection, Mol. Immunol., 2015, vol. 63, no. 2, pp. 193–202.
Di, X., Bai, N., Zhang, X., Liu, B., Ni, W., Wang, J., et al., A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity, Braz. J. Infect. Dis., 2015, vol. 19, no. 4, pp. 339–349.
Tao, S., Chen, H., Li, N., Wang, T., and Liang, W., The spread of antibiotic resistance genes in vivo model, Can. J. Infect. Dis. Med. Microbiol., 2022, vol. 2022, p. 3348695.
Heidari, H., Sedigh Ebrahim-Saraie, H., Amanati, A., Motamedifar, M., Hadi, N., and Bazargani, A., Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile, Iran. J. Basic Med. Sci., 2019, vol. 22, no. 7, pp. 813–819.
Huang, H., Weintraub, A., Fang, H., and Nord, C.E., Antimicrobial resistance in Clostridium difficile, Int. J. Antimicrob. Agents, 2009, vol. 34, no. 6, pp. 516–522.
Yang, J., Zhang, X., Liu, X., Cai, L., Feng, P., Wang, X., et al., Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates, Diagn. Microbiol. Infect. Dis., 2017, vol. 89, no. 2, pp. 161–163.
Hunt, M., Mather, A.E., Sánchez-Busó, L., Page, A.J., Parkhill, J., Keane, J.A., et al., ARIBA: Rapid antimicrobial resistance genotyping directly from sequencing reads, Microb. Genomics, 2017, vol. 3, no. 10, p. e000131.
Huang, Y., Niu, B., Gao, Y., Fu, L., and Li, W., CD-HIT Suite: A web server for clustering and comparing biological sequences, Bioinformatics, 2010, vol. 26, no. 5, pp. 680–682.
Li, H., Minimap and miniasm: Fast mapping and de novo assembly for noisy long sequences, Bioinformatics, 2016, vol. 32, no. 14, pp. 2103–2110.
Kurtz, S., Phillippy, A., Delcher, A.L., Smoot, M., Shumway, M., Antonescu, C., et al., Versatile and open software for comparing large genomes, Genome Biol., 2004, vol. 5, no. 2, p. R12.
Langmead, B. and Salzberg, S.L., Fast gapped-read alignment with Bowtie 2, Nat. Methods, 2012, vol. 9, no. 4, pp. 357–359.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., et al., The sequence Alignment/Map format and SAMtools, Bioinformatics, 2009, vol. 25, no. 16, pp. 2078–2079.
Leeds, J.A., Sachdeva, M., Mullin, S., Barnes, S.W., and Ruzin, A., In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin, J. Antimicrob. Chemother., 2014, vol. 69, no. 1, pp. 41–44.
Wang, S., Zhou, Y., Zhao, B., Ou, X., Xia, H., Zheng, Y., et al., Characteristics of compensatory mutations in the rpoC gene and their association with compensated transmission of Mycobacterium tuberculosis, Front. Med., 2020, vol. 14, no. 1, pp. 51–59.
Xu, Z., Zhou, A., Wu, J., Zhou, A., Li, J., Zhang, S., et al., Transcriptional approach for decoding the mechanism of rpoC compensatory mutations for the fitness cost in rifampicin-resistant Mycobacterium tuberculosis, Front. Microbiol., 2018, vol. 9, p. 2895.
Matsuo, M., Hishinuma, T., Katayama, Y., and Hiramatsu, K., A mutation of RNA polymerase β′ subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into “Slow VISA,” Antimicrob. Agents Chemother., 2015, vol. 59, no. 7, pp. 4215–4225.
Elhadidy, M., Miller, W.G., Arguello, H., Álvarez-Ordóñez, A., Dierick, K., and Botteldoorn, N., Molecular epidemiology and antimicrobial resistance mechanisms of Campylobacter coli from diarrhoeal patients and broiler carcasses in Belgium, Transboundary Emerging Dis., 2019, vol. 66, no. 1, pp. 463–475.
Yang, T., Pan, L., Wu, N., Wang, L., Liu, Z., Kong, Y., et al., Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying quinolone resistance, Antimicrob. Agents Chemother., 2020, vol. 64, no. 6, p. e02560-19.
Reygaert, W.C., An overview of the antimicrobial resistance mechanisms of bacteria, AIMS Microbiol., 2018, vol. 4, no. 3, pp. 482–501.
Arenz, S., Nguyen, F., Beckmann, R., and Wilson, D.N., Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution, Proc. Natl. Acad. Sci. U. S. A., 2015, vol. 112, no. 17, pp. 5401–5406.
Wilson, D.N., Hauryliuk, V., Atkinson, G.C., and O’Neill, A.J., Target protection as a key antibiotic resistance mechanism, Nat. Rev. Microbiol., 2020, vol. 18, no. 11, pp. 637–648.
Dinos, G.P., The macrolide antibiotic renaissance, Br. J. Pharmacol., 2017, vol. 174, no. 18, pp. 2967–2983.
ACKNOWLEDGMENTS
For the support and data supply authors would like to express deep thanks to department of Biotechnology, College of Science, University of Anbar.
Funding
This work was supported by ongoing institutional funding. No additional grants to carry out or direct this particular research were obtained.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
This work does not contain any studies involving human and animal subjects.
CONFLICT OF INTEREST
The authors of this work declare that they have no conflicts of interest.
Additional information
Publisher’s Note.
Allerton Press remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Al-Rawe, A.M., Yousif, Y.I., Al-Jomaily, O.K. et al. Identification of Antimicrobial Resistance Genes and Drug Targets in Antibiotic-Resistant Clostridioides difficile Clinical Isolates. Mol. Genet. Microbiol. Virol. 38, 197–206 (2023). https://doi.org/10.3103/S0891416823030023
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0891416823030023